India bumps certifications to national level

Prompted by WHO concerns, Indian drug makers will begin approaching national regulatory authorities rather than state administrators to get facilities and export products certified. The switch, effective next month, is an attempt to streamline the regulatory process for pharmaceutical exports, but some expect it to add delays. Article